Please login to the form below

Not currently logged in
Email:
Password:

AstraZeneca partners with cooking website

AstraZeneca has entered into a partnership with Food University, a web-based culinary platform, to discuss healthy eating in support of the company's cholesterol drug Crestor

AstraZeneca (AZ) has entered into a partnership with Food University, a web-based culinary platform, to help educate consumers about healthy eating in support of the company's medication Crestor (rosuvastatin calcium), which is approved to lower cholesterol in combination with diet and exercise.

The partnership "aims to empower people to take control of their health by showing how even small changes, like incorporating more low-cholesterol foods into their diet, can make a big difference," the company said. "AstraZeneca hopes the information and tools provided through the Food University partnership will help people learn how to integrate healthy eating and cooking habits into their everyday routines."

Launched to coincide with National Nutrition Month in March, the partnership will include a video series in which Food University chefs provide cooking demonstrations and offer tips and recipes for healthy meals.

In addition, the recipes will be included from AZ's website for Crestor, which already offers visitors some healthy eating tools, including a seven-day, low-cholesterol meal planner.

Crestor, a "super-statin" launched in 2003, has been one of AstraZeneca's top-selling products, bringing in $4.5bn in 2009.

14th March 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

ema1
The European Medicines Agency: PRIME’d for access?
Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...

Infographics